Global Diabetic Neuropathy Epidemiology and Patient Flow Analysis - 2016

Global Diabetic Neuropathy Epidemiology and Patient Flow Analysis - 2016

  • January 2016 •
  • Report ID: 3895243 •
  • Format: PDF
Fore Pharma announced the results of its Diabetic Neuropathy patient population study in a new report ‘Global Diabetic Neuropathy Epidemiology and Patient Flow Analysis - 2016’. The report provides insights into Diabetic Neuropathy epidemiology, Diabetic Neuropathy diagnosed patients, and Diabetic Neuropathy treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Diabetic Neuropathy derived from epidemiological analysis, percentage of patients diagnosed with Diabetic Neuropathy, and percentage of patients treated with Diabetic Neuropathy therapy.

The study helps executives estimate Diabetic Neuropathy market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Diabetic Neuropathy prevalence, Diabetic Neuropathy diagnosis rate, and Diabetic Neuropathy treatment rate for the period 2015 - 2022. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:
- Diabetic Neuropathy: Disease Definition
- Diabetic Neuropathy Patient Flow
- Diabetic Neuropathy Prevalence
- Diabetic Neuropathy Diagnosed Patients
- Diabetic Neuropathy Treated Patients